Exane BNP Paribas analyst Chris Bottiglieri downgrades Best Buy Co (NYSE:BBY) from Outperform to Neutral.
Is Federal Cannabis Legalization A Double-Edged Sword? The Answer Is Complicated
"The real catalyst is going to be federal legalization.
Exane BNP Paribas Downgrades Best Buy Co to Neutral
Exane BNP Paribas analyst Chris Bottiglieri downgrades Best Buy Co (NYSE:BBY) from Outperform to Neutral.
Related Posts
Analyst Ratings for Acadia Healthcare Co
Within the last quarter, Acadia Healthcare Co (NASDAQ:ACHC) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent…
Goldman Sachs Likely To Report Lower Q3 Earnings; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts
The Goldman Sachs Group, Inc. (NYSE: GS) is expected to release financial results for its third quarter, before the opening bell on Oct. 17, 2023.
Toll Brothers Stock Is Moving Higher On Q3 Earnings: The Details
Toll Brothers Inc (NYSE: TOL) shares are trading higher in Tuesday's after-hours session on the heels of the company's third-quarter results.